Drugs / GNRH-A Goserelin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05617885 Background | Aug 2023 → Jul 2025 | metastatic prostate carcinoma | Praful Ravi, MB BCHir, MRCP | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GNRH-A Goserelin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05617885 ↗ |
| Route | Subcutaneous | “Administered via subcutaneous injection” NCT05617885 ↗ |